C. R. Bard, Inc. today announced that it has acquired certain assets from PST, LLC, of Gainesville, Florida, related to new self-expanding nitinol stent technology. Terms of the transaction were not disclosed. Self-expanding stents are used to maintain patency within anatomical lumens, such as those associated with peripheral vascular, urological, biliary and tracheal-bronchial applications. The technology acquired includes a development stage stent specifically designed to have the flexibility to meet the demands of tortuous and dynamic anatomy.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060118005478&newsLang=en)